Search Results - "TSAPEPAS, Demetra S"

COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter by Pereira, Marcus R., Mohan, Sumit, Cohen, David J., Husain, Syed A., Dube, Geoffrey K., Ratner, Lloyd E., Arcasoy, Selim, Aversa, Meghan M., Benvenuto, Luke J., Dadhania, Darshana M., Kapur, Sandip, Dove, Lorna M., Brown, Robert S., Rosenblatt, Russell E., Samstein, Benjamin, Uriel, Nir, Farr, Maryjane A., Satlin, Michael, Small, Catherine B., Walsh, Thomas J., Kodiyanplakkal, Rosy P., Miko, Benjamin A., Aaron, Justin G., Tsapepas, Demetra S., Emond, Jean C., Verna, Elizabeth C.

“…Solid organ transplant recipients may be at a high risk for SARS‐CoV‐2 infection and poor associated outcomes. We herein report our initial experience with…”
Get full text

Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline by Powell, Jaclyn T., Tsapepas, Demetra S., Martin, Spencer T., Hardy, Mark A., Ratner, Lloyd E.

“…Ischemia reperfusion injury (IRI) is an early, non‐specific inflammatory response that follows perfusion of warm blood into a cold asanguinous organ following…”
Get full text

Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients by Qin, Caroline X., Moore, Linda W., Anjan, Shweta, Rahamimov, Ruth, Sifri, Costi D., Ali, Nicole M., Morales, Megan K., Tsapepas, Demetra S., Basic-Jukic, Nikolina, Miller, Rachel A., van Duin, David, Santella, Robert N., Wadei, Hani M., Shah, Pali D., Gage, Nikki, Malinis, Maricar, Aslam, Saima, Todesco, Eve, Werbel, William A., Avery, Robin K., Segev, Dorry L.

Get full text

Prevalence and predictors of SARS‐CoV‐2 antibodies among solid organ transplant recipients with confirmed infection by Burack, Daniel, Pereira, Marcus R., Tsapepas, Demetra S., Harren, Patricia, Farr, Maryjane A., Arcasoy, Selim, Cohen, David J., Mohan, Sumit, Emond, Jean C., Hod, Eldad A., Verna, Elizabeth C.

“…It remains uncertain whether immunocompromised patients including solid organ transplant (SOT) recipients will have a robust antibody response to SARS‐CoV‐2…”
Get full text

UNOS Decisions Impact Data Integrity of the OPTN Data Registry by Tsapepas, Demetra S., King, Kristen, Husain, Syed Ali, Yu, Miko E., Hippen, Benjamin E., Schold, Jesse D., Mohan, Sumit

“…Background. The Organ Procurement Transplant Network (OPTN)/United Network for Organ Sharing (UNOS) registry is an important national registry in the field of…”
Get full text

Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials by Lange, Nicholas W., King, Kristen, Husain, Syed Ali, Salerno, David M., Tsapepas, Demetra S., Hedvat, Jessica, Yu, Miko, Mohan, Sumit

“…Though belatacept is administered with a weight-based dosing schema, there has been higher clearance reported in obese patients. Therefore, we evaluated the…”
Get full text

Outcomes of COVID‐19 in solid organ transplant recipients: A matched cohort study by Pereira, Marcus R., Arcasoy, Selim, Farr, Maryjane A., Mohan, Sumit, Emond, Jean C., Tsapepas, Demetra S., Shi, Qiuhu, Purpura, Lawrence, Uhlemann, Anne‐Catrin, Zucker, Jason, Verna, Elizabeth C.

“…Whether solid organ transplant (SOT) recipients are at increased risk of poor outcomes due to COVID‐19 in comparison to the general population remains…”
Get full text

Tocilizumab for severe COVID‐19 in solid organ transplant recipients: a matched cohort study by Pereira, Marcus R., Aversa, Meghan M., Farr, Maryjane A., Miko, Benjamin A., Aaron, Justin G., Mohan, Sumit, Cohen, David J., Husain, Syed A., Ratner, Lloyd E., Arcasoy, Selim, Uriel, Nir, Zheng, Elizabeth X., Fox, Alyson N., Tsapepas, Demetra S., Emond, Jean C., Verna, Elizabeth C.

“…The safety and efficacy of tocilizumab for the treatment of severe respiratory symptoms due to COVID‐19 remain uncertain, in particular among solid organ…”
Get full text

Managing the significant interaction between XR tacrolimus and fluconazole in kidney transplant recipients by Lange, Nicholas W., Hedvat, Jessica, Tsapepas, Demetra S., Salerno, David M.

Get full text

Home Care Delivery and Remote Patient Monitoring of Kidney Transplant Recipients During COVID-19 Pandemic by Chang, Jae-Hyung, Sritharan, Sharlinee, Schmitt, Kevin, Patel, Shefali, Crew, R. John, Tsapepas, Demetra S.

“…Telehealth plays a critical role in the response of healthcare organizations during the COVID-19 pandemic. While telemedicine offers a real-time…”
Get full text

Managing the atazanavir–tacrolimus drug interaction in a renal transplant recipient by Tsapepas, Demetra S, Webber, Allison B, Aull, Meredith J, Figueiro, Jose M, Saal, Stuart D

“…The management of the drug interaction between atazanavir and tacrolimus in a renal transplant recipient is described. A 53-year-old African-American man with…”
Get full text

Natural Antibodies Are Associated With Rejection and Long-term Renal Allograft Loss in a Multicenter International Cohort by See, Sarah B., Yang, Xue, Burger, Carole, Lamarthée, Baptiste, Snanoudj, Renaud, Shihab, Ronzon, Tsapepas, Demetra S., Roy, Poulomi, Larivière-Beaudoin, Stéphanie, Hamelin, Katia, Mendoza Rojas, Aleixandra, van Besouw, Nicole M., Bartosic, Amanda, Daniel, Nikita, Rodica, Vasilescu E., Mohan, Sumit, Cohen, David, Ratner, Lloyd, Baan, Carla C., Bromberg, Jonathan S., Cardinal, Héloïse, Anglicheau, Dany, Sun, Yifei, Zorn, Emmanuel

“…Potentially harmful nonhuman leukocyte antigen antibodies have been identified in renal transplantation, including natural immunoglobulin G antibodies (Nabs)…”
Get full text

Using technology to enhance medication regimen education after solid organ transplantation by Tsapepas, Demetra S, Salerno, David, Jandovitz, Nicholas, Hammad, Sara, Jordan, Patrick, Mohan, Sumit, Hardy, Mark, Kotchoubey, Helen, Vawdrey, David, Fleischut, Peter M

“…PURPOSE.The design and implementation of a tool that combines clinical teaching with cutting-edge, simplified technology for providing medication education to…”
Get full text

Using known drug interactions to manage supratherapeutic calcineurin inhibitor concentrations by Lange, Nicholas W., Salerno, David M., Berger, Karen, Tsapepas, Demetra S.

“…Objectives To summarize the available body of evidence guiding the management of supratherapeutic concentrations of calcineurin inhibitors (CNI) using…”
Get full text

Telehealth in outpatient management of kidney transplant recipients during COVID‐19 pandemic in New York by Chang, Jae‐Hyung, Diop, Mohamed, Burgos, Yvonne L., Blackstock, Daryle M., Fernandez, Hilda E., Morris, Heather K., Dube, Geoffrey K., Crew, Russell John, Mohan, Sumit, Husain, Syed Ali, Cohen, David J., Tsapepas, Demetra S.

Get full text

Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents by Avasare, Rupali S, Rosenstiel, Paul E, Zaky, Ziad S, Tsapepas, Demetra S, Appel, Gerald B, Markowitz, Glen S, Bomback, Andrew S, Canetta, Pietro A

“…Most studies that have assessed the predictors of recurrent IgA nephropathy (IgAN) in the renal allograft have focused on post-transplant features. Identifying…”
Get more information

Association between the “Timed Up and Go Test” at transplant evaluation and outcomes after kidney transplantation by Michelson, Ariane T., Tsapepas, Demetra S., Husain, S. Ali, Brennan, Corey, Chiles, Mariana C., Runge, Brian, Lione, Jennifer, Kil, Byum H., Cohen, David J., Ratner, Lloyd E., Mohan, Sumit

“…Background Studies have demonstrated the Timed Up and Go Test's (TUGT) ability to forecast postoperative outcomes for several surgical specialties. Evaluations…”
Get full text

Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population by Tiwari, Ruchi, Tsapepas, Demetra S, Powell, Jaclyn T, Martin, Spencer T

“…Healthcare organizations continue to adopt information technologies with clinical decision support (CDS) to prevent potential medication-related adverse drug…”
Get full text

Dynamic Interplay of Pharmacy Learners During a Solid Organ Transplantation Learning Experience by Sin, Jonathan H., Li, Hanlin, Jandovitz, Nicholas, King, Madeline, Tsapepas, Demetra S.

“…Institutions with established clinical pharmacy services have the ability to offer focused patient care learning experiences, often led by a clinical…”
Get full text

Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation by Tsapepas, Demetra S, Vasilescu, Rodica, Tanriover, Bekir, Coppleson, Yael, Rekhtman, Yelena, Hardy, Mark A, Dube, Geoffrey, Crew, R John, Ratner, Lloyd E, Cohen, David J, Mohan, Sumit

“…Allograft outcomes in patients undergoing repeat renal transplantation are inferior compared to first-time transplant recipient outcomes. Donor-specific…”
Get full text